CIK 0001842952
- Emerging growth company
Context Therapeutics Inc.
Sign in to watch- Ticker
- CNTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 863738787
- Phone
- +1 267-225-7416
- Business address
- 2001 MARKET STREET, SUITE 3915 UNIT #15, PHILADELPHIA, PA, 19103
- Former names
- Context Therapeutics LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-24 | Walker Luke Nathaniel Director | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2025-06-12 | Walker Luke Nathaniel Director | Grant or award · Stock Option (right to buy) | +123,500 | 123,500 | ||
| 2024-09-04 | Walker Luke Nathaniel Director | Grant or award · Stock Option (right to buy) | +19,315 | 19,315 |
Page 1 of 1 · 3 trades